Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial
The Journal of Dermatology · 2026
DOI: 10.1111/1346-8138.70425 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Taiki Nozaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Osteitis, Psoriasis. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyowa Kirin Co., Ltd..
Abstract (Originalsprache)
Pustulotic arthro‐osteitis (PAO) is a clinically important osteoarticular comorbidity affecting approximately 9%–28% of patients with palmoplantar pustulosis (PPP), yet early recognition and standardized activity assessment remain challenging, particularly in routine dermatology practice. This exploratory analysis evaluated patients with PAO to identify potential indicators of disease activity. A magnetic resonance imaging (MRI)‐based scoring system for the anterior chest wall (ACW) in patients with PAO was developed. This post hoc analysis used data from the PAO subgroup of patients with PPP enrolled in a previous phase 3 trial. Correlations were assessed between clinical indicators—Ankylosing Spondylitis Disease Activity Score, Assessment of SpondyloArthritis international Society Health Index score, physicians' Numeric Rating Scale‐PAO (NRS‐PAO) activity score, and patients' NRS‐PAO pain score—and MRI indicators, including active lesions such as bone marrow edema extent and intensity, and structural lesions in the ACW, spine, and sacroiliac joints (Spondyloarthritis Research Consortium of Canada [SPARCC] score); the correlations between MRI indicators and plain radiographic indicators were also evaluated. Of 20 included patients (mean age: 56.6 years), the majority were female. MRI examinations detected bone marrow edema in all patients. None of the clinical indicators showed a clear association with MRI indicators. There was no clear association between radiographic indicators and the bone marrow edema extent or intensity scores of lesions in the ACW. The spine SPARCC score was positively correlated with the osteosclerosis score of the ACW (| r | = 0.70; p = 0.0218) and the modified Stoke Ankylosing Spondylitis Spinal Score of the spine (| r | = 0.93; p < 0.001). The MRI‐based ACW scoring system may provide a feasible method to standardize disease activity assessment in PAO in clinical practice. Further external validation is warranted, and additional clinical indicators are needed to predict disease activity. Trial Registration: NCT04061252, UMIN000055398
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- Department of Radiology, University of Iowa, Iowa City, Iowa, USA.
- Medical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Taiki Nozaki, Manabu Arai, Junko Ochi, Mona Uchida-Yamada, Masahiro Hashimoto, Mitsuhiro Akiyama, Yuko Kaneko, Yasumasa Kanai, Masahiro Jinzaki
Förderung
- Kyowa Kirin Co., Ltd.
Zitieren
APA
Nozaki, T., Arai, M., Ochi, J., Uchida-Yamada, M., Hashimoto, M., Akiyama, M., Kaneko, Y., Kanai, Y., & Jinzaki, M. (2026). Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70425
Vancouver
Nozaki T, Arai M, Ochi J, Uchida-Yamada M, Hashimoto M, Akiyama M, et al. Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70425
BibTeX
@article{Nozaki2026,
author = {Nozaki, Taiki and Arai, Manabu and Ochi, Junko and Uchida-Yamada, Mona and Hashimoto, Masahiro and Akiyama, Mitsuhiro and Kaneko, Yuko and Kanai, Yasumasa and Jinzaki, Masahiro},
title = {Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial},
journal = {The Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70425}
}
EUVIMED